Three Dose Levels of a Maternal Respiratory Syncytial Virus Vaccine Candidate Are Well Tolerated and Immunogenic in a Randomized Trial in Nonpregnant Women - Schwarz, TF; Johnson, C; Grigat, C (J Infect Dis, 2022)